Similar Articles
Evaluation of personality disorders using the structured clinical interview for DSM-5 personality disorders, quality of life, and disease activity in patients with systemic lupus erythematosus
Yunus Durmaz, İlker İlhanlı, Pınar Durmaz
DOI: 10.46497/ArchRheumatol.2022.9002
Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study
Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee
DOI: 10.46497/ArchRheumatol.2022.9140
Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi
DOI: 10.46497/ArchRheumatol.2022.9217
The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec
DOI: 10.46497/ArchRheumatol.2022.9255
MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis
Xinglan Huang, Peng Yan, Xinghua Song, Suiying Zhang, Yuqiong Deng, Caifeng Huang, Xiaoqing Zhao, Sheng Liu, Xiping Cheng, Dongjiang Liao
DOI: 10.46497/ArchRheumatol.2022.9168
The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients
Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed
DOI: 10.46497/ArchRheumatol.2022.9307
Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus
Yuewu Tang, Yi Luo
DOI: 10.46497/ArchRheumatol.2022.9167
Role of low-density lipoprotein receptor rs5925 (1959C>T) gene polymorphism in pathogenesis of dyslipidemia among Egyptian lupus nephritis patients
Yumn A. Alsabbagh, Saher A. Ahmed, Heba E. Salama, Mai A. Abd-Elmawla, Hala L. Elgendy
DOI: 10.46497/ArchRheumatol.2022.9247
Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?
Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin
DOI: 10.46497/ArchRheumatol.2022.9366
Serum cystatin C and βeta-2 microglobulin as potential biomarkers in children with lupus nephritis
Eman Baraka, Nashwa Hashaad, Walid Abdelhalim, Gehan Elolemy
DOI: 10.46497/ArchRheumatol.2023.8520
Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up
Rasha N Yousef, Abeer Ramadan, Eman Awadallah, Alshaimaa R Alnaggar, Noha M Khalil, Mervat E.Behiry, Asmaa Ali, Hesham Gamal El Dine
DOI: 10.46497/ArchRheumatol.2023.9448
Association between levels of serum and urinary B cell-activating factor and systemic lupus erythematosus disease activity
Maryam Rezazadeh, Mohammad Hasan Jokar, Seyedeh Mehrnaz Aghili, Zahra Mirfeizi, Mahmoud Mahmoudi, Negar Morovatdar, Kamila Hashemzadeh
DOI: 10.46497/ArchRheumatol.2023.9549
Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies
Sherif Gamal, Hanaa Rady, Nesreen Sobhy, Ibrahem Siam, Ahmed Soliman, Fatema Elgengehy
DOI: 10.46497/ArchRheumatol.2023.9860
The effects of Lactobacillus delbrueckii and Lactobacillus rhamnosus on cytokines and their related molecules: An ex vivo study on patients with systemic lupus erythematosus
Atefeh Alaei, Mahmoud Mahmoudi, Maryam Sahebari, Zohreh Vahidi, Nafiseh Tabasi, Maryam Rastin
DOI: 10.46497/ArchRheumatol.2023.9941
Interactions between TNFAIP3, PTPN22, and TRAF1-C5 gene polymorphisms in patients with primary Sjögren's syndrome
Daniel Cadena-Sandoval, Isela Montúfar-Robles, Rosa Elda Barbosa-Cobos, Gabriela Hernández-Molina, Ana Karen Salas-García, Norma Sánchez-Zauco, Julian Ramírez-Bello
DOI: 10.46497/ArchRheumatol.2024.10108
Left ventricular systolic function assessed by standard and advanced echocardiographic techniques in patients with systemic lupus erythematosus: A systemic review and meta-analysis
Maka Gegenava, Zviad Kirtava, William KF Kong, Tea Gegenava
DOI: 10.46497/ArchRheumatol.2024.10131
Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus
Lingyan He, Mingming Yan, Rui Wen, Jiali Li
DOI: 10.46497/ArchRheumatol.2024.9977